Fidelity Covington Trust (FMED)
Management Company · XNMS · Series S000079688 · View on SEC EDGAR ↗
$25.27
As of March 10, 2026
▼ -0.26 (-1.02%)
1-day change
$20.69 – $29.07
52-week range
- Net assets
- $41.0M
- Holdings
- 70
- As of
- May 31, 2026
- Top 10 holdings weight
- 39.44%
- Effective number of positions
- 32.4
- Positions above 1%
- 46
On this page
- Price chart The fund's market price over time, with technical overlays.
- Performance Total return, volatility, drawdown and other risk metrics.
- Fund flows Money flowing in and out of the fund each month, from N-PORT filings.
- Holdings Every position the fund currently holds, with weights.
- Sector breakdown How the fund's holdings split across market sectors.
- Institutional owners 13F institutions that report holding this ETF.
- Similar funds Other funds with overlapping holdings or comparable size.
FMED Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
Performance as of March 10, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▼ -2.40% | — |
| 3M | ▼ -9.75% | — |
| 6M | ▲ +2.49% | — |
| YTD | ▼ -6.60% | — |
| 1Y | ▲ +7.79% | — |
| 3Y | — | — |
| 5Y | — | — |
| Max since Feb. 27, 2024 | ▼ -1.33% | — |
- Volatility 1Y
- 20.67%
- Volatility 3Y
- —
- Max drawdown 3Y
- —
- Beta 3Y
- —
- Sharpe 1Y*
- 0.47
Total return is shown once dividend history for this fund has been collected — price return alone would duplicate it misleadingly. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
- Last month (May 2026)
- -$17.4M
- Quarter ending May 2026
- -$17.4M
- Trailing 12 months
- -$12.2M
Jun 2025 – May 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 70 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| Fidelity Revere Street Trust | 31635A303 | $4.2M | 10.27 | 4,206,098 | STIV | US |
| UCB SA | — | $1.9M | 4.73 | 6,605 | EC | BE |
| LIFESTANCE HEALTH GROUP INC | 53228F101 | $1.8M | 4.27 | 227,100 | EC | US |
| DANAHER CORP | 235851102 | $1.4M | 3.42 | 7,675 | EC | US |
| 10X GENOMICS INC | 88025U109 | $1.3M | 3.11 | 45,000 | EC | US |
| INTUITIVE SURGICAL INC | 46120E602 | $1.2M | 2.92 | 2,816 | EC | US |
| COGENT BIOSCIENCES INC | 19240Q201 | $1.2M | 2.85 | 33,428 | EC | US |
| ALNYLAM PHARMACEUTICALS INC | 02043Q107 | $1.1M | 2.79 | 3,791 | EC | US |
| ARGENX SE | 04016X101 | $1.1M | 2.78 | 1,365 | EC | NL |
| LEGEND BIOTECH CORP | 52490G102 | $940K | 2.29 | 34,614 | EC | KY |
| UNITEDHEALTH GROUP INC | 91324P102 | $922K | 2.25 | 2,424 | EC | US |
| BIO TECHNE CORP | 09073M104 | $919K | 2.24 | 17,786 | EC | US |
| ASCENDIS PHARMA A/S | — | $866K | 2.11 | 3,865 | EC | DK |
| EDWARDS LIFESCIENCES CORP | 28176E108 | $865K | 2.11 | 10,000 | EC | US |
| MODERNA INC | 60770K107 | $863K | 2.11 | 18,282 | EC | US |
| KYMERA THERAPEUTICS INC | 501575104 | $814K | 1.99 | 10,000 | EC | US |
| XENON PHARMACEUTICALS INC | 98420N105 | $786K | 1.92 | 14,366 | EC | CA |
| HEARTFLOW INC | 42238D107 | $774K | 1.89 | 24,994 | EC | US |
| SARTORIUS STEDIM BIOTECH | — | $755K | 1.84 | 3,633 | EC | FR |
| INSMED INC | 457669307 | $735K | 1.79 | 6,875 | EC | US |
| VEEVA SYS INC | 922475108 | $730K | 1.78 | 4,188 | EC | US |
| VAXCYTE INC | 92243G108 | $723K | 1.77 | 14,071 | EC | US |
| REVOLUTION MEDICINES INC | 76155X100 | $709K | 1.73 | 4,504 | EC | US |
| CARIS LIFE SCIENCES INC | 142152107 | $702K | 1.71 | 41,991 | EC | US |
| CRINETICS PHARMACEUTICALS INC | 22663K107 | $675K | 1.65 | 19,000 | EC | US |
| AXSOME THERAPEUTICS INC | 05464T104 | $645K | 1.57 | 2,752 | EC | US |
| CYTOKINETICS INC | 23282W605 | $634K | 1.55 | 8,262 | EC | US |
| VERACYTE INC | 92337F107 | $631K | 1.54 | 13,621 | EC | US |
| THERMO FISHER SCIENTIFIC INC | 883556102 | $628K | 1.53 | 1,276 | EC | US |
| BRIGHTSPRING HEALTH SERVICES INC | 10950A106 | $628K | 1.53 | 10,187 | EC | US |
| PRIVIA HEALTH GROUP INC | 74276R102 | $605K | 1.48 | 28,119 | EC | US |
| BOSTON SCIENTIFIC CORP | 101137107 | $589K | 1.44 | 12,185 | EC | US |
| NATERA INC | 632307104 | $584K | 1.43 | 2,615 | EC | US |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | — | $581K | 1.42 | 12,000 | EC | GB |
| GUARDANT HEALTH INC | 40131M109 | $567K | 1.38 | 4,375 | EC | US |
| STRYKER CORP | 863667101 | $559K | 1.36 | 1,832 | EC | US |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | $548K | 1.34 | 31,100 | EC | US |
| ALIGNMENT HEALTHCARE INC | 01625V104 | $511K | 1.25 | 33,378 | EC | US |
| LONZA GROUP AG | — | $500K | 1.22 | 780 | EC | CH |
| NUVALENT INC | 670703107 | $497K | 1.21 | 4,504 | EC | US |
| STOKE THERAPEUTICS INC | 86150R107 | $484K | 1.18 | 15,670 | EC | US |
| DISC MEDICINE INC | 254604101 | $482K | 1.18 | 6,926 | EC | US |
| DEXCOM INC | 252131107 | $482K | 1.18 | 6,533 | EC | US |
| INSULET CORP | 45784P101 | $451K | 1.10 | 3,112 | EC | US |
| ELI LILLY and CO | 532457108 | $436K | 1.07 | 395 | EC | US |
| ENLIVEN THERAPEUTICS INC | 29337E102 | $424K | 1.03 | 10,703 | EC | US |
| CYTOMX THERAPEUTICS INC | 23284F105 | $403K | 0.98 | 112,069 | EC | US |
| WAYSTAR HOLDING CORP | 946784105 | $402K | 0.98 | 20,187 | EC | US |
| IRHYTHM TECHNOLOGIES INC | 450056106 | $395K | 0.96 | 3,471 | EC | US |
| KESTRA MEDICAL TECHNOLOGIES INC | — | $391K | 0.95 | 18,400 | EC | BM |
Page 1
of 2
← Previous
Next →
Sector breakdown
Healthcare
77.7%
Other/Unmapped
22.3%
Institutional owners (13F) 12 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| FMR LLC | $20,165,641 | 90.88% | 706,946 | Shares | June 30, 2026 |
| JANE STREET GROUP, LLC | $1,422,256 | 6.41% | 49,860 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $282,283 | 1.27% | 9,896 | Shares | June 30, 2026 |
| OLD MISSION CAPITAL LLC | $257,295 | 1.16% | 9,020 | Shares | June 30, 2026 |
| Farther Finance Advisors, LLC | $26,386 | 0.12% | 925 | Shares | June 30, 2026 |
| UBS Group AG | $12,323 | 0.06% | 432 | Shares | June 30, 2026 |
| Parallel Advisors, LLC | $11,239 | 0.05% | 394 | Shares | June 30, 2026 |
| OSAIC HOLDINGS, INC. | $3,252 | 0.01% | 114 | Shares | June 30, 2026 |
| Central Pacific Bank - Trust Division | $2,767 | 0.01% | 97 | Shares | June 30, 2026 |
| Glen Eagle Advisors, LLC | $2,567 | 0.01% | 90 | Shares | June 30, 2026 |
| Glass Jacobson Investment Advisors llc | $1,427 | 0.01% | 50 | Shares | June 30, 2026 |
| MERCER GLOBAL ADVISORS INC /ADV | $1,426 | 0.01% | 50 | Shares | June 30, 2026 |
Peer funds
More from this issuer
| Fund | AUM |
|---|---|
| FBND Fidelity Merrimack Street Trust | $26.1B |
| FTEC FIDELITY COVINGTON TRUST | $17.9B |
| ONEQ Fidelity Commonwealth Trust | $10.9B |
| FDVV FIDELITY COVINGTON TRUST | $9.2B |
| FBCG FIDELITY COVINGTON TRUST | $6.2B |
| FSEC Fidelity Merrimack Street Trust | $4.5B |
| FHLC FIDELITY COVINGTON TRUST | $2.9B |
| FUTY FIDELITY COVINGTON TRUST | $2.5B |
| FSMD FIDELITY COVINGTON TRUST | $2.4B |
| FNCL FIDELITY COVINGTON TRUST | $2.2B |
Similar by size
| Fund | AUM |
|---|---|
| XPND First Trust Exchange-Traded Fun… | $41.1M |
| CPSJ Calamos ETF Trust | $41.2M |
| NVBU AIM ETF Products Trust | $41.2M |
| XJAN First Trust Exchange-Traded Fun… | $41.2M |
| PSCJ Pacer Funds Trust | $41.2M |
| OVF Listed Funds Trust | $40.8M |
| FCBD Advisors' Inner Circle Fund II | $40.7M |
| OCTB ETF Series Solutions | $40.5M |
| JPMO Tidal Trust II | $40.5M |
| ZTRE RBB Fund, Inc. | $40.5M |